JEREMY B. HAYDEN, General Counsel & VP of BD at Plus Therapeutics, holds 163.56K shares in Sight Sciences (Ticker: SGHT), holds 32.04K shares in Endologix (Ticker: ELGXQ), holds 26.20K shares in Plus Therapeutics (Ticker: PSTV). Most recently, JEREMY B. HAYDEN Sold ― shares of Sight Sciences on Jul 03, 2024 for an estimated value of 31.39K.
What is the percentage of profitable transactions made by JEREMY B. HAYDEN?
The percentage of profitable transactions made by JEREMY B. HAYDEN is 0%.
What is the average return per transaction made by JEREMY B. HAYDEN?
The average return per transaction made by JEREMY B. HAYDEN is -46.30%.
What stocks does JEREMY B. HAYDEN hold?
JEREMY B. HAYDEN holds: PSTV, ELGXQ, SGHT stocks.
What was JEREMY B. HAYDEN’s latest transaction?
JEREMY B. HAYDEN latest transaction was an Informative Sell of $31.39K.
What was JEREMY B. HAYDEN's most profitable transaction?
JEREMY B. HAYDEN’s most profitable transaction was an Informative Sell of SGHT stock on July 3, 2024. The return on the trade was -22.90%.
What is JEREMY B. HAYDEN's role in Plus Therapeutics?
JEREMY B. HAYDEN's role in Plus Therapeutics is General Counsel & VP of BD.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.